Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Brain Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07763886
What this trial is testing

CORRELATION BETWEEN FORWARD HEAD POSTURE, CERVICAL MUSCLES ENDURANCE, AND PROPRIOCEPTIVE FUCTIONS IN CERVICOGENIC HEADACHE AMONG LATE ADOLESCENT STUDENTS.

Who this might be right for
Cervicogenic Headache
Delta University for Science and Technology 100
Testing effectiveness (Phase 2)Study completedNCT03967522
What this trial is testing

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 26
Not applicableEnded earlyNCT01419574
What this trial is testing

Ultrasound and Other Images of Artery Blockages

Who this might be right for
Atherosclerosis
National Heart, Lung, and Blood Institute (NHLBI) 12
Early research (Phase 1)WithdrawnNCT02145910
What this trial is testing

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT00003320
What this trial is testing

Radiation Therapy Following Surgery to Remove Brain Metastases

Who this might be right for
Metastatic Cancer
Jonsson Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07505173
What this trial is testing

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Who this might be right for
Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases
Tianjin Medical University Cancer Institute and Hospital 74
Not applicableLooking for participantsNCT04033497
What this trial is testing

Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

Who this might be right for
Brain Tumor
Brigham and Women's Hospital 101
Not applicableStudy completedNCT01974804
What this trial is testing

Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 30
Not applicableLooking for participantsNCT07119047
What this trial is testing

Brazilian Adaptation of an Intervention Developed in Ireland to Promote Healthy Lifestyle Behaviors Post-stroke: a Feasibility Study

Who this might be right for
Stroke
Federal University of Minas Gerais 10
Not applicableStudy completedNCT07132047
What this trial is testing

Mulligan SNAG Versus Active Release Technique in Cervicogenic Headache

Who this might be right for
Cervicogenic Headache
University of Lahore 72
Testing effectiveness (Phase 2)Ended earlyNCT00538343
What this trial is testing

RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases

Who this might be right for
Brain Metastases
Biogen 14
Not applicableStudy completedNCT07405047
What this trial is testing

Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases

Who this might be right for
Brain Metastases, Adult
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 33
Not applicableUnknownNCT03027544
What this trial is testing

Tomotherapy for Refractory Brain Metastases

Who this might be right for
Brain Metastases
Chinese Academy of Medical Sciences 150
Not applicableStudy completedNCT02150304
What this trial is testing

Aminophylline Prophylaxis For Postdural Puncture Headache

Who this might be right for
Postdural Puncture Headache
Diskapi Yildirim Beyazit Education and Research Hospital 100
Early research (Phase 1)Study completedNCT00003712
What this trial is testing

CCI-779 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center at San Antonio 15
Testing effectiveness (Phase 2)Ended earlyNCT03911869
What this trial is testing

An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis

Who this might be right for
Brain Metastases
Pfizer 13
Testing effectiveness (Phase 2)UnknownNCT06088056
What this trial is testing

A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesRadiotherapy
Fudan University 17
Early research (Phase 1)Study completedNCT02820454
What this trial is testing

Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles

Who this might be right for
Brain Metastases
University Hospital, Grenoble 15
Not applicableStudy completedNCT05243953
What this trial is testing

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

Who this might be right for
Post-Traumatic Headache
Danish Headache Center 21
Large-scale testing (Phase 3)Study completedNCT00766545
What this trial is testing

Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

Who this might be right for
Cerebral Infarction
Otsuka Pharmaceutical Co., Ltd. 1,095
Next Page